Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravitreal Infliximab for Refractory Uveitis in Behçet's Disease
NCT02620618Phase 2Completed
- Sponsor
- Cairo University
- Start
- Jan 2013
- Primary completion
- Dec 2014
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of infliximab in Behçet's disease (BD), uveitis, sponsored by Cairo University. Started Jan 2013; status: completed.
02
Drugs
infliximab
03
Conditions
Behçet's disease (BD)uveitis
Beyond the preview
Go deeper on NCT02620618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02620618.